Chugai Pharmaceutical Financials
| CHGCF Stock | USD 46.34 5.27 12.83% |
Chugai |
Understanding current and past Chugai Pharmaceutical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Chugai Pharmaceutical's financial statements are interrelated, with each one affecting the others. For example, an increase in Chugai Pharmaceutical's assets may result in an increase in income on the income statement.
Chugai Pharmaceutical Stock Summary
Chugai Pharmaceutical competes with Sanofi ADR, Bristol Myers, AstraZeneca PLC, Gilead Sciences, and Novartis. Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. Chugai Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7664 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 2-1-1 Nihonbashi-Muromachi, Chuo, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—General |
| Benchmark | Dow Jones Industrial |
| Website | www.chugai-pharm.co.jp |
| Phone | 81 3 3281 6611 |
| Currency | USD - US Dollar |
Chugai Pharmaceutical Key Financial Ratios
There are many critical financial ratios that Chugai Pharmaceutical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Chugai Pharmaceutical reports annually and quarterly.Chugai Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Chugai Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Chugai Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chugai Pharmaceutical competition to find correlations between indicators driving Chugai Pharmaceutical's intrinsic value. More Info.Chugai Pharmaceutical Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.68 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Chugai Pharmaceutical Co is roughly 1.47 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Chugai Pharmaceutical's earnings, one of the primary drivers of an investment's value.Chugai Pharmaceutical Systematic Risk
Chugai Pharmaceutical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Chugai Pharmaceutical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Chugai Pharmaceutical correlated with the market. If Beta is less than 0 Chugai Pharmaceutical generally moves in the opposite direction as compared to the market. If Chugai Pharmaceutical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Chugai Pharmaceutical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Chugai Pharmaceutical is generally in the same direction as the market. If Beta > 1 Chugai Pharmaceutical moves generally in the same direction as, but more than the movement of the benchmark.
Chugai Pharmaceutical November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Chugai Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Chugai Pharmaceutical Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Chugai Pharmaceutical Co based on widely used predictive technical indicators. In general, we focus on analyzing Chugai Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Chugai Pharmaceutical's daily price indicators and compare them against related drivers.
| Downside Deviation | 6.21 | |||
| Information Ratio | (0) | |||
| Maximum Drawdown | 36.2 | |||
| Value At Risk | (9.20) | |||
| Potential Upside | 7.21 |
Complementary Tools for Chugai Pink Sheet analysis
When running Chugai Pharmaceutical's price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges |